A clinical research study designed to test high and low dose Topiramate to see if this medication can be used to decrease drinking behaviors and increase smoking abstinence.
The goal of this clinical research study is to learn about the safety of varenicline (Chantix/Champix) and of bupropion (Wellbutrin/Zyban) compared to placebo and nicotine-replacement therapy (“the patch”—NRT) when given to smokers with or without a history of mental health disorders. Researchers also want to learn if varenicline, bupropion, and NRT can help people with and without mental health disorders quit smoking.
The goal of this research study is to learn more about how smokers’ and non-smokers’ brains respond to visual stimuli. This study is currently recruiting Non-Smokers from the community. This study is supported by grant number 1R01DA032581-01A1from the National Institute on Drug Abuse to Francesco Versace.
CENIC stands for the Center for the Evaluation for Nicotine in Cigarettes. It is a multi-site study for people who are willing to try cigarettes with varying levels of nicotine. The FDA will use this information to regulate tobacco products with the goal of improving public health.
The goal of this research study is to learn more about how smoker's brains respond to cues in their environment and how smoking a cigarette influences brain responses. Brain responses will be measured using a functional magnetic resonance imaging (fMRI) scanner.
For questions about our lab, please contact:
- Regina Richards
Senior Administrative Assistant
- Altoya Bazile-Robertson
Interested in quitting smoking? For more information about any of our smoking cessation studies, call 713-792-2265.
Interested in participating in our non-quit research studies? Call the non-quit line at 713-794-4763 for more information.